financetom
Business
financetom
/
Business
/
Cintas Surpasses Q3 Estimates With Strong Growth, Raises FY25 EPS Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cintas Surpasses Q3 Estimates With Strong Growth, Raises FY25 EPS Outlook
Mar 26, 2025 7:54 AM

Cintas Corporation ( CTAS ) reported third-quarter earnings per share of $1.13 on Wednesday, beating the street view of $1.06. Quarterly sales of $2.609 billion (+8.4% year over year) outpaced the analyst consensus estimate of $2.597 billion.

The company’s shares are trading higher following the announcement of the results.

The organic revenue growth rate for the third quarter, which adjusts for the impacts of acquisitions and foreign currency exchange rate fluctuations, was 7.9%.

Quarterly gross profit was $1.32 billion, an increase of 11.1% year over year. Gross margin expanded to 50.6% from 49.4% in last year’s third quarter, an increase of 120 basis points.

Also Read: Rivian Doubles Down On EV Innovation With Micromobility Spin-Off, Stock Gains

Operating income for the third quarter increased 17.1% to $609.9 million. Operating margin was 23.4%, compared to 21.6% in last year’s third quarter.

Todd M. Schneider, Cintas’ President and Chief Executive Officer, stated, “Cintas delivered strong revenue growth, operating margins and cash flow generation in the third quarter.”

The company exited the quarter with cash and equivalents worth $243.428 million. Inventories were $420.826 million.

On March 14, Cintas ( CTAS ) paid an aggregate quarterly dividend of $158.1 million to shareholders, an increase of 14.9% from the amount paid last March.

Related Read: No Deal: Cintas Abandons UniFirst Proposal After Talks Hit A Wall

Outlook: Cintas ( CTAS ) raises FY25 outlook. The company sees revenues of $10.28 billion – $10.305 billion versus $10.296 billion estimate (prior view: $10.255 billion – $10.32 billion).

The company attributed the $15.0 million reduction at the top of the range to the negative impact of the foreign currency exchange rate fluctuations experienced in the third quarter and the expected impact for the fourth quarter. 

The firm projects EPS of $4.36 – $4.44 versus the $4.32 estimate (prior view: $4.28 – $4.34).

Price Action: CTAS shares are trading higher by 8.1% to $209.14 at last check Wednesday.

Read Next:

What’s Going On With Electronics Maker Kopin’s Stock Today?

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
West Pharmaceutical beats Q3 net sales estimates; lifts FY revenue, EPS outlook
West Pharmaceutical beats Q3 net sales estimates; lifts FY revenue, EPS outlook
Oct 23, 2025
Overview * West Pharmaceutical Services ( WST ) Q3 net sales up 7.7%, beating analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * Company raises full-year 2025 revenue and EPS guidance, citing ongoing momentum Outlook * West Pharmaceutical raises full-year 2025 revenue guidance to $3.060 bln-$3.070 bln * Company increases full-year 2025 adjusted EPS guidance...
Unilever CFO says SEC automatic approval could see ice cream demerger in December
Unilever CFO says SEC automatic approval could see ice cream demerger in December
Oct 23, 2025
LONDON (Reuters) -Unilever CFO Srinivas Phatak said on Thursday the demerger of the group's ice cream business could happen in early December if The Magnum Ice Cream Company listing gains automatic SEC approval following the publication of its prospectus next month. Unilever ( UL ) is delaying the ice cream spin-off due to the U.S. government shutdown and Phatak said...
Materials science company Dow misses Q3 net sales estimates
Materials science company Dow misses Q3 net sales estimates
Oct 23, 2025
Overview * Dow Q3 net sales fell 8% yr/yr, missing analysts' expectations * Adjusted EPS for Q3 beats consensus despite a yr/yr decline * Company achieved sequential EBIT growth through cost reductions and operational improvements Outlook * Dow aims to deliver over $6.5 bln in near-term cash support * Company focuses on resilient portfolio areas to capture market share and...
Dow posts smaller-than-expected quarterly loss on lower costs, resilient demand
Dow posts smaller-than-expected quarterly loss on lower costs, resilient demand
Oct 23, 2025
Oct 23 (Reuters) - Chemicals company Dow Inc ( DOW ) posted a smaller-than-expected adjusted quarterly loss in the third quarter on Thursday, helped by lower costs, higher volumes from new U.S. Gulf Coast assets, and stronger demand in industrial markets, even as global chemical prices remained weak. Shares of Dow were up 1.4% at $22.00 in premarket trading. Chemical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved